COCP Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza with IC50 <50 nM Potency
Cocrystal Pharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.12
-8.9% in 1d after detection
Post-detection moves
1h
+2.0%
1d
-8.9%
3d
-8.9%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS